ALEXANDRIA, Va., June 9 -- United States Patent no. 12,286,408, issued on April 29, was assigned to Biohaven Therapeutics Ltd. (Tortola, British Virgin Islands).
"KV7 channel activators compositions and methods of use" was invented by Michael E. Bozik (Wexford, Pa.), Scott S. Harried (Sun Prairie, Conn.), Lynn Resnick (Pittsburgh), George T. Topalov (Pittsburgh), Justin K. Belardi (Pittsburgh), Charles A. Flentge (Mars, Pa.), David A. Mareska (Pittsburgh) and James S. Hale (Pittsburgh).
According to the abstract* released by the U.S. Patent & Trademark Office: "Provided herein are optionally substituted benzoimidazol-1,2-yl amides, pharmaceutical compositions comprising a therapeutically effective amount of such compounds and a pharmaceut...